| Members |
targetComponentId |
| Canis familiaris |
Canis lupus subspecies familiaris (organism) |
| Canis rufus |
Canis lupus subspecies rufus (organism) |
| Cannabinoid |
Cannabis (substance) |
| Cannabinoid - non-pharmaceutical |
Cannabis (substance) |
| cannabisberoende med nuvarande användning |
Cannabis dependence |
| kannabisgräs, icke läkemedel |
Cannabis (substance) |
| kannabisblad, icke läkemedel |
Cannabis leaf (substance) |
| kannabisolja, icke läkemedel |
Cannabis oil (substance) |
| kannabisharts, icke läkemedel |
Cannabis resin (substance) |
| Cannulation - action |
Insertion - action (qualifier value) |
| kapillära hemangiom, kategori |
Capillary hemangioma |
| Capnocytophaga canimorsus |
Capnocytophaga canimorsus |
| Caprine adenovirus |
Goat adenovirus (organism) |
| kapsaicin 179 mg/timme, depåplåster |
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) |
| kapsel i distal interfalangealled i stortå, struktur |
Structure of capsule of interphalangeal joint of great toe |
| kaptoprilallergi |
Non-allergic hypersensitivity to captopril (finding) |
| karbakol 1 %, ögondroppar |
Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| karbakol 1,5 %, ögondroppar |
Carbachol 15 mg/mL eye solution |
| Carbachol 1.5% solution |
Carbachol 15 mg/mL eye solution |
| karbakol 250 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml |
Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| karbamazepin 100 mg, kapsel med modifierad frisättning |
Carbamazepine only product in oral dose form |
| karbamazepin 100 mg, tablett med modifierad frisättning |
Carbamazepine only product in oral dose form |
| karbamazepin 100 mg, depåkapsel |
Carbamazepine only product in oral dose form |
| karbamazepin 100 mg, depåtablett |
Carbamazepine only product in oral dose form |
| karbamazepin 200 mg, kapsel med modifierad frisättning |
Carbamazepine only product in oral dose form |
| karbamazepin 200 mg, depåkapsel |
Carbamazepine only product in oral dose form |
| karbamazepin 300 mg, kapsel med modifierad frisättning |
Carbamazepine only product in oral dose form |
| karbamazepin 300 mg, depåkapsel |
Carbamazepine only product in oral dose form |
| karbenoxolonnatrium 1 %, granulat till munsköljvätska |
Carbenoxolone only product |
| karbenoxolonnatrium 2 %, oral gel |
Carbenoxolone 20 mg/g oromucosal gel |
| karbidopa 25 mg + levodopa 100 mg, tablett med modifierad frisättning |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| karbidopa 10 mg + levodopa 100 mg, munsönderfallande tablett |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| karbidopa 18,75 mg + levodopa 75 mg + entakapon 200 mg, tablett |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
| Carbidopa 25mg |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug) |
| karbidopa 25 mg + levodopa 100 mg, munsönderfallande tablett |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| karbidopa 25 mg + levodopa 250 mg, munsönderfallande tablett |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
| karbidopa 31,25 mg + levodopa 125 mg + entakapon 200 mg, tablett |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
| karbinoxaminmaleat 1 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, droppar |
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
| karbinoxaminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 12,5 mg/5 ml + pseudoefedrinhydroklorid 60 mg/5 ml, sirap |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
| karbinoxaminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 15 mg/5 ml + pseudoefedrinhydroklorid 60 mg/5 ml, sirap |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
| karbinoxaminmaleat 1 mg/ml+ pseudoefedrinhydroklorid 15 mg/ml, droppar |
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution |
| karbinoxaminmaleat + pseudoefedrinhydroklorid 8 mg/120 mg, tablett med modifierad frisättning |
Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form) |
| karbinoxaminmaleat 8 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form) |
| Carbohydrate agent |
Carbohydrate |
| karbolfuksin |
Carbol-fuchsin (substance) |
| Carbon-carbon lyase |
Carbon-carbon lyase |
| Carbon-halide lyase |
Carbon-halide lyase |
| Carbon-nitrogen lyase |
Carbon-nitrogen lyase |
| Carbon-oxygen lyase |
Carbon-oxygen lyase |
| Carbon-sulfur lyase |
Carbon-sulfur lyase (substance) |
| Carboxy-lyase |
Decarboxylase |
| Carboxylic ester hydrolase |
Carboxylesterase |
| karboximetylcellulosanatrium + hydroxiapatit, injicerbart implantat, spruta 1 ml |
Carmellose and hydroxyapatite only product in parenteral dose form |
| karboximetylcellulosanatrium 16,58 %, oral pasta |
Carmellose 166 mg/g oromucosal paste |
| Carbuncle of head, except face |
Carbuncle of head |
| Carbuncle of other specified site |
Carbuncle of skin and/or subcutaneous tissue (disorder) |
| karcinoidtumör (förutom i appendix, M-82401) |
Malignant carcinoid tumor |
| Carcinoid tumor, argentaffin |
Carcinoid tumor - argentaffin |
| carcinoma in situ, kategori |
Carcinoma in situ (morphologic abnormality) |
| Carcinoma in situ neoplastic process |
Carcinoma in situ (morphologic abnormality) |
| Carcinoma in situ tumour |
Carcinoma in situ (disorder) |
| carcinoma in situ |
Carcinoma in situ (morphologic abnormality) |
| Carcinoma liver/biliary system NOS |
Carcinoma liver and/or biliary system (disorder) |
| livmoderhalskarcinom stadium 0 |
Carcinoma in situ of uterine cervix |
| fynd som rör TNM-stadieindelning av carcinom i huden (utom i ögonlock, vulva och penis) utom melanom |
American Joint Committee on Cancer allowable value |
| bröstcancerliknande karcinom |
Carcinoma (morphologic abnormality) |
| karcinom |
Carcinoma (morphologic abnormality) |
| Cardiac end diastolic volume, function (observable entity) |
Cardiac end-diastolic volume (observable entity) |
| biverkning av hjärtglykosid |
Adverse reaction to Digitalis glycoside |
| Cardiac status not worse than preoperative baseline |
Cardiac status is consistent with or improved from preoperative baseline (finding) |
| Cardiomyopathy due to drugs and other external agents |
Cardiomyopathy caused by drug |
| Cardiospasm |
Achalasia of esophagus |
| kardiotuberkulös cirros |
Cirrhosis of liver |
| tillsyn av hickmankateter |
Care of central venous catheter (regime/therapy) |
| Care of venous dissection |
Procedure on cardiovascular system |
| Care plan |
Care plan (record artifact) |
| vårdplan |
Care plan (record artifact) |
| Care plan |
Care plan (record artifact) |
| vårdar person med psykisk funktionsnedsättning i beroendeställning |
Caregiver of dependent with intellectual disability |
| Carglumic acid 200mg dispersible tablet |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
| karglutamsyra 200 mg, dispergerbar tablett |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
| omhändertagande miljö |
Caring environment (finding) |
| Carlavirus group |
Genus Carlavirus (organism) |
| karmellosnatrium 0,5 %, ögondroppar |
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
| karmellosnatrium 1 %, ögondroppar |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
| karmellosnatrium 1 %, ögondroppar för engångsbruk |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
| karmustinskiva 7,7 mg |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
| Carnobacterium piscicola |
Carnobacterium maltaromaticum (organism) |
| Carotenosis cutis |
Carotene pigmentation of skin |
| Carpenter-Waziris syndrom |
X-linked intellectual disability hypotonic face syndrome |
| karvedilol 10 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 10 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 20 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 20 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 40 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 40 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 80 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 80 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| Carya illinoensis |
Carya illinoinensis (organism) |
| extrakt av pekannöt |
Carya illinoinensis diagnostic allergen extract (product) |
FHIR